Doxorubicin Hydrochloride Injectable, Liposomal
Product Images NDC 72603-103

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 72603-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 mg 10ml Carton

20 mg 10ml Carton
Packaging label for Doxorubicin Hydrochloride Liposome Injection, 20 mg/10 mL (2 mg/mL) injectable liposomal solution. The label includes dosing and storage instructions, a barcode, manufacturer information (NorthStar Rx LLC and Sun Pharmaceutical Ind. Ltd.), and emphasizes that it is a liposomal formulation that must be diluted prior to intravenous infusion. The product is a 10 mL single-dose vial, with storage recommended at 2°C to 8°C.*
FDA Label Image

20 mg 10ml Label

20 mg 10ml Label
Label for Doxorubicin Hydrochloride Liposome Injection, 20 mg/10 mL (2 mg/mL) injectable liposomal formulation. It is a cytotoxic agent for intravenous infusion only after dilution. The label includes storage instructions (refrigerate 2°C to 8°C, do not freeze), dispensing cautions, manufacturer information (Northstar Rx LLC, Memphis, TN and Sun Pharmaceutical Ind. Ltd., India), and packaging details as a 10 mL single-dose vial.*
FDA Label Image

50 mg 25ml Carton

50 mg 25ml Carton
Packaging label for Doxorubicin Hydrochloride Liposome Injection, 50 mg/25 mL (2 mg/mL) injectable liposomal formulation by NorthStar Rx LLC and Sun Pharmaceutical Industries Ltd. The label highlights that the product is sterile, cytotoxic, must be diluted prior to IV administration, and contains a single-dose 25 mL vial. Storage instructions include refrigeration at 2°C to 8°C and a warning to not freeze.*
FDA Label Image

50 mg 25ml Label

50 mg 25ml Label
Label for Doxorubicin Hydrochloride Liposome Injection 50 mg/25 mL (2 mg/mL) injectable liposomal solution. It is a cytotoxic agent for intravenous infusion only after dilution, must be diluted using 5% Dextrose Injection USP. The label states it is a single-dose 25 mL vial, manufactured for Northstar Rx LLC and by Sun Pharmaceutical Ind. Ltd. Storage instructions include refrigeration at 2°C to 8°C (36°F to 46°F) and to not freeze. Contains a barcode and lot/expiration placeholders.*
FDA Label Image

Spl-doxorubicin-figure (Spl Doxorubicin Figure)

Spl-doxorubicin-figure (Spl Doxorubicin Figure)
An illustration depicting the structure of a pegylated liposome used for Doxorubicin Hydrochloride injectable. The diagram labels the MPEG-DSPE coating on the outer surface, the liposomal bilayer, and the aqueous core containing entrapped doxorubicin HCl in the center.*
FDA Label Image

Spl-doxorubicin-figure1 (Spl Doxorubicin Figure1)

Spl-doxorubicin-figure1 (Spl Doxorubicin Figure1)
A Kaplan-Meier survival curve comparing the percent of subjects progression-free over 15 months for two treatment groups: Doxorubicin plus Bortezomib and Bortezomib alone. The graph shows higher progression-free survival for the combination therapy group. Number of subjects at risk at various time points is listed below the graph, along with statistical values including p-value and hazard ratio (HR).*
FDA Label Image

Spl-doxorubicin-structure (Spl Doxorubicin Structure)

Spl-doxorubicin-structure (Spl Doxorubicin Structure)
Chemical structure diagram of Doxorubicin Hydrochloride depicting the molecular arrangement including hydroxyl, methoxy, and amine functional groups along with the hydrochloride (HCl) component.*
FDA Label Image

Spl-doxorubicin-structure1 (Spl Doxorubicin Structure1)

Spl-doxorubicin-structure1 (Spl Doxorubicin Structure1)
Chemical structure of MPEG-DSPE, a compound shown in the structural formula illustration with its chemical groups and phosphate moiety detailed.*
FDA Label Image

Spl-doxorubicin-structure2 (Spl Doxorubicin Structure2)

Spl-doxorubicin-structure2 (Spl Doxorubicin Structure2)
Chemical structure diagram labeled as HSPC, showing a phospholipid with quaternary ammonium, phosphate, glycerol, and fatty acid chains of variable lengths (m,n = 14 or 16).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.